Conference programme NCHIV 2024 

08:15Registration
Opening remarks
09:15Opening and introductionsBoard stichting NCHIV
SESSION 1: HIV in the Netherlands
Chairs: Anouk Urbanus (RIVM) and Jet Gisolf (Rijnstate)
09:25 - 10:25SHM 2024 Monitoring Report highlights:
- HIV in the Netherlands
- Impact of socio-economic variables on outcomes: transition from data to action
- Clinical highlights

Ard van Sighem (SHM)
Vita Jongen (SHM)
Ferdinand Wit (SHM)
10:25 - 10:35O.01: Accounting for pre- and post-migration infection in estimates of the HIV epidemic in the NetherlandsArd van Sighem (SHM)
10:35 - 10:45O.02: The socioeconomic costs of living with HIV in the Netherlands – Diagnosis and labour market outcomesAndrei Tuiu (UvA)
10:45 - 10:55O.03: Online and less frequent monitoring of oral HIV PrEP use are non-inferior to standard of care: results from the EZI-PrEP randomized controlled trialMarije Groot Bruinderink (GGD Amsterdam)
10:55Refreshment break
SESSION 2: Longterm Health and Preferences of People with HIV
Chairs: Aafke Cents-Bosma (Flevoziekenhuis) and Andre van der Ven (Radboudumc)
11:25 - 11:50Plenary: Geriatric Syndromes: Increasing Awareness of Factors Affecting Health-span of Aging PLWH Julian Falutz (McGill University Health Centre, Canada)
11:50 - 12:00Moderated Q&A
12:00 - 12:10O.04: Evaluating the 10-year risk of recurrent cardiovascular events and potential effects of secondary prophylaxis in people with HIVRosa Elias (UMC Utrecht)
12:10 - 12:20O.05: HIV-infected microglia drive transcriptional and metabolic changes in complex human brain organoidsLeanne Helgers (Amsterdam UMC)
12:20 - 12:30O.06: Postmortem analyses of the central nervous system in individuals with HIV demonstrate that infection of microglia contributes to inflammatory pathways despite viral suppressionMarieke Nühn (UMC Utrecht)
12:30 - 12:40O.07: Impact of ART simplification with dolutegravir and lamivudine on the HIV reservoir and systemic inflammationAlexander Pasternak (Amsterdam UMC)
12:40 - 12:50O.08: A discrete choice experiment investigating preferences for long-acting regimes in people with HIVKyra Mendes de Leon (Amsterdam UMC)
12:50 - 14:15Lunch and poster presentations
SESSION 3: Ensuring Globally Inclusive HIV Cure Research
Chairs: Tokameh Mahmoudi (Erasmus MC) & Godelieve de Bree (Amsterdam UMC)
14:15Introduction to the SPIRAL programmeTokameh Mahmoudi (Erasmus MC)
14:20 - 14:40Plenary: Translating the HIV remission/cure research to Sub-Saharan AfricaThumbi Ndung'u (Africa Health Research Institute, Univ. of KwaZulu-Natal, South Africa)
14:40 - 15:00Multidisciplinary presentations by SPIRAL investigators:
- HIV subtypes and cure

- Biological sex and HIV Cure
- Interdisciplinarity and stakeholder engagement
- Infrastructure and capacity building
Cynthia Lungu (Centre for Infectious Disease Research in Zambia/Erasmus MC)
Shringar Rao (Erasmus MC)
Kim Romijnders (UMC Utrecht)
Sarah Stutterheim (Maastricht University)
15:00 - 15:15Moderated panel discussion
15:15 - 15:25O.09: Using Nanobodies as an Intracellular Biological to Block Production of HIV-1 Through Innate Antiviral MechanismsFlorence Stel (Amsterdam UMC)
15:25 - 15:35O.10: Human vaccination induces broad recognition of the CD4 binding site on HIV-1 envelope glycoprotein in a phase 1 clinical trial Catarina Mendes Silva (Amsterdam UMC)
15:35Refreshment break
SESSION 4: Preventing HIV and STI's
Chairs: Henry de Vries (GGD Amsterdam, Amsterdam UMC) and Sacha de Stoppelaar (RIVM)
16:05 - 16:15O.11: New HIV-1 diagnoses amongst different generations of MSM in the Netherlands – focus on Gen-ZDaniela Bezemer (SHM)
16:15 - 16:25O.12: Preparing for long-acting PrEP delivery: Provider preferences for the provision of long-acting PrEP differ between MSM and heterosexual individuals in Europe Hanne Zimmermann (Maastricht University)
16:25 - 16:35O.13: Emergent informal use of doxycycline post- and pre-exposure prophylaxis (doxyPEP/PrEP) among men who have sex with men and transgender and gender diverse people in the NetherlandsBuhari Teker (GGD Amsterdam)
Doxycycline post-exposure prophylaxis: are we ready to implement?
16:35 - 16:50IntroductionHenry de Vries
16:50 - 17:20Moderated panel discussion to address both data gaps and controversial issues on the road to implementation
Moderators: Henry de Vries and Sacha de Stoppelaar

Panelists:
Mark van den Elshout MD, Physician Society & Health, profile Infectious Disease Control (GGD Regio Utrecht)
Sebastiaan Verboeket MD Resident in Addiction Medicine (Radboudumc) and community representative
Alje van Dam, medical microbiologist (Amsterdam UMC & Streeklaboratorium GGD Amsterdam)
Patricia Bloem, general practitioner (Amsterdam) & Staff Team Professionals Soa Aids Nederland
Kai Jonas, professor of applied social psychology (Maastricht University)
17:20Presentation of Joep Lange & Jacqueline van Tongeren Junior Investigator and NCHIV Best Poster Award & Closing
Board Stichting NCHIV
17:30Drinks

 

NCHIV is organised by
With additional support from: